In terms of management for<unk> , immunosuppressive therapy should be used depending on the disease presented. A C1-INH concentrate can be used for angio-oedema (C1-INH<unk> . Pneumococcus and Haemophilus infections can be prevented via immunization. Epsilon-aminocaproic acid could be used to treat hereditary C1-INH<unk> , though the possible side effect of intravascular thrombosis should be weighed.
Complement deficiency
Complement 2 deficiency
Complement 3 deficiency
Terminal complement pathway deficiency
IgG deficiency
T cell deficiency
Neutrophil-specific granule deficiency
Leukocyte adhesion deficiency